Clinicopathological prognostic factors and the role of cytoreduction in surgical stage IVb endometrial cancer: A retrospective multi-institutional analysis of 248 patients in Japan

Gynecologic Oncology

Volumn 127, Issue 2, 2012, Pages 338-344

  Eto, Takako ^a   Saito, Toshiaki ^a   Kasamatsu, Takahiro ^b   Nakanishi, Toru ^c   Yokota, Harushige ^d   Satoh, Toyomi ^e   Nogawa, Takayoshi ^f   Yoshikawa, Hiroyuki ^e   Kamura, Toshiharu ^g   Konishi, Ikuo ^h  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d SAITAMA CANCER CENTER   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION   (Japan)

^g KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h KYOTO UNIVERSITY   (Japan)

Author keywords

Extra abdominal metastases; Prognostic factor; Stage IVb endometrial cancer; Surgical cytoreduction

Indexed keywords

DOXORUBICIN; PLATINUM;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; JAPAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OMENTUM METASTASIS; OVARY METASTASIS; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOSARCOMA; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; JAPAN; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84867402896     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.08.012     Document Type: Article

References (24)

1. F. Amant, P. Moerman, P. Neven, D. Timmerman, E. Van Limbergen, and I. Vergote Endometrial cancer Lancet 366 9484 2005 491 505
2. P.G. Rose Endometrial carcinoma N Engl J Med 335 9 1996 640 649
3. W.T. Creasman, F. Odicino, P. Maisonneuve, M.A. Quinn, U. Beller, and J.L. Benedet Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer Int J Gynaecol Obstet 95 Suppl. 1 2006 S105 S143
4. A. Ayhan, C. Taskiran, C. Celik, K. Yuce, and T. Kucukali The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer Int J Gynecol Cancer 12 5 2002 448 453
5. R. Numazaki, E. Miyagi, K. Konnai, M. Ikeda, A. Yamamoto, and R. Onose Analysis of stage IVB endometrial carcinoma patients with distant metastasis: a review of prognoses in 55 patients Int J Clin Oncol 14 4 2009 344 350
6. Y. Ueda, T. Enomoto, T. Miyatake, T. Egawa-Tanaka, H. Ugaki, and K. Yoshino Endometrial carcinoma with extra-abdominal metastasis: improved prognosis following cytoreductive surgery Ann Surg Oncol 17 4 2010 1111 1117
7. R.E. Bristow, M.J. Zerbe, N.B. Rosenshein, F.C. Grumbine, and F.J. Montz Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival Gynecol Oncol 78 2 2000 85 91
8. B.A. Goff, A. Goodman, H.G. Muntz, A.F. Fuller Jr., N. Nikrui, and L.W. Rice Surgical stage IV endometrial carcinoma: a study of 47 cases Gynecol Oncol 52 2 1994 237 240
9. D.S. Chi, M. Welshinger, E.S. Venkatraman, and R.R. Barakat The role of surgical cytoreduction in stage IV endometrial carcinoma Gynecol Oncol 67 1 1997 56 60
10. K.K. Shih, E. Yun, G.J. Gardner, R.R. Barakat, D.S. Chi, and M.M. Leitao Jr. Surgical cytoreduction in stage IV endometrioid endometrial carcinoma Gynecol Oncol 122 3 2011 608 611
11. R.E. Bristow, L.R. Duska, and F.J. Montz The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma Gynecol Oncol 81 1 2001 92 99
12. M.B. Thomas, A. Mariani, W.A. Cliby, G.L. Keeney, K.C. Podratz, and S.C. Dowdy Role of cytoreduction in stage III and IV uterine papillary serous carcinoma Gynecol Oncol 107 2 2007 190 193
13. J.N. Barlin, I. Puri, and R.E. Bristow Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis Gynecol Oncol 118 1 2010 14 18
14. J.G. Aalders, V. Abeler, and P. Kolstad Stage IV endometrial carcinoma: a clinical and histopathological study of 83 patients Gynecol Oncol 17 1 1984 75 84
15. A. du Bois, A. Reuss, E. Pujade-Lauraine, P. Harter, I. Ray-Coquard, and J. Pfisterer Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO) Cancer 115 6 2009 1234 1244
16. A.P. Makar, M. Baekelandt, C.G. Trope, and G.B. Kristensen The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer Gynecol Oncol 56 2 1995 175 180
17. B.E. Greer, and A.D. Hamberger Treatment of intraperitoneal metastatic adenocarcinoma of the endometrium by the whole-abdomen moving-strip technique and pelvic boost irradiation Gynecol Oncol 16 3 1983 365 373
18. N.C. Lambrou, O. Gomez-Marin, R. Mirhashemi, H. Beach, E. Salom, and Z. Almeida-Parra Optimal surgical cytoreduction in patients with stage III and stage IV endometrial carcinoma: a study of morbidity and survival Gynecol Oncol 93 3 2004 653 658
19. S. Memarzadeh, C.H. Holschneider, R.E. Bristow, N.L. Jones, Y.S. Fu, and B.Y. Karlan FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival Int J Gynecol Cancer 12 5 2002 454 458
20. M.E. Randall, V.L. Filiaci, H. Muss, N.M. Spirtos, R.S. Mannel, and J. Fowler Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study J Clin Oncol 24 1 2006 36 44
21. G.F. Fleming, V.L. Brunetto, D. Cella, K.Y. Look, G.C. Reid, and A.R. Munkarah Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study J Clin Oncol 22 11 2004 2159 2166
22. A.A. Secord, L.J. Havrilesky, V. Bae-Jump, J. Chin, B. Calingaert, and A. Bland The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer Gynecol Oncol 107 2 2007 285 291
23. H.D. Homesley, V. Filiaci, S.K. Gibbons, H.J. Long, D. Cella, and N.M. Spirtos A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a Gynecologic Oncology Group study Gynecol Oncol 112 3 2009 543 552
24. P.J. Hoskins, K.D. Swenerton, J.A. Pike, F. Wong, P. Lim, and C. Acquino-Parsons Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study J Clin Oncol 19 20 2001 4048 4053